Encephalitis Lethargica
Information Page |
NINDS is part of the
National Institutes of
Health
Table of Contents (click to jump to sections)
What is Encephalitis Lethargica?
Is there any treatment?
What is the prognosis?
What research is being done?
Organizations
Additional resources from MEDLINEplus
What is Encephalitis Lethargica?
Encephalitis lethargica is a disease characterized by high fever, headache, double vision, delayed physical and mental response,
and lethargy. In acute cases, patients may enter coma. Patients may also experience abnormal eye movements, upper body weakness,
muscular pains, tremors, neck rigidity, and behavioral changes including psychosis. The cause of encephalitis lethargica is
unknown. Between 1917 to 1928, an epidemic of encephalitis lethargica spread throughout the world, but no recurrence of the
epidemic has since been reported. Postencephalitic Parkinson's disease may develop after a bout of encephalitis-sometimes
as long as a year after the illness.
Is there any treatment?
What is the prognosis?
What research is being done?
Select this link to view a list of studies currently seeking patients.
National Organization for Rare Disorders (NORD) P.O. Box 1968 (55 Kenosia Avenue) Danbury, CT 06813-1968 orphan@rarediseases.org http://www.rarediseases.org Tel: 203-744-0100 Voice Mail 800-999-NORD (6673) Fax: 203-798-2291 |
Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892
NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history.
All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated.
Last updated February 12, 2007